Mr. Peter Bakema reports
CVR MEDICAL CORP. RETAINS
RENMARK FINANCIAL COMMUNICATIONS INC.
CVR Medical Corp. has retained the
services of Renmark Financial Communications Inc. to handle its investor relations activities.
"We are pleased to announce that we have selected Renmark to reinforce CVR Medical Corp.'s
profile in the financial community and enhance the visibility of our company. We choose Renmark
because its standards and methodologies fit best with the message we wish to communicate to the
investing public," noted Peter Bakema, chief executive officer of CVR Medical.
In consideration of the services to be provided, the monthly fees incurred by CVR Medical will be a cash consideration of up to $8,000, starting Jan. 1, 2018, for a period of six
months ending on June 30, 2018, and monthly thereafter.
Renmark Financial Communications does not have any interest, directly or indirectly, in CVR Medical
or its securities, or any right or intent to acquire such an interest.
About CVR Medical
CVR Medical is a company that is involved in an equal-part joint venture with CVR Global Inc. The joint venture operates in the medical industry focused on the commercialization of a
proprietary subsonic, infrasonic and low-frequency sound wave analysis technology and has patents to a
diagnostic device designed to detect and measure carotid arterial stenosis.
© 2021 Canjex Publishing Ltd. All rights reserved.